Decline in new immigrant students puts newcomer programs in jeopardy
Top Takeaways Schools cite a sharp decline in enrollment among new immigrant students this school year as border crossings have dropped. California had a record-high 236,958 immigrant students, equivalent to 1 in every 25 public school students, in 2024-25. Oakland Unified established...
California charter school oversight bill faces challenges, future uncertain
Top Takeaways Oversight of 1,280 charter schools is needed after scandals involving theft and mismanagement. One reform bill was pulled, and another was vetoed by Gov. Gavin Newsom in the Legislature. Both bills included provisions to establish a statewide Office of the Education Inspector...
Trade groups urge swift USMCA renewal with key sector revisions
Organizations representing auto parts makers to consumer brands are pushing for duty-free trade and stronger cross-border economic ties. Continue reading →
Truckload market faces lackluster Q4 outlook, improvement in 2026
Recent interest rates cuts could help manufacturing, a critical driver of freight activity, broker RXO said. Continue reading →
Hamas-Linked Hackers Probe Middle Eastern Diplomats
Hamas’s best hackers have been maturing, building better malware, and spreading their attacks more widely across the region. Continue reading →
Pace appoints Ken Beyer as CEO
Pace, a science and technology company specialising in environmental and life sciences laboratories, has announced the appointment of Ken Beyer as its new CEO. Beyer’s experience to date spans logistics, technology and consulting. He was previously CEO of Transportation Insight and Nolan...
Actithera appoints Darshan Dalal as Chief Medical Officer
Actithera has announced the appointment of Dr Darshan Dalal as its new Chief Medical Officer. Dalal brings over 15 years of leadership experience in oncology and haematology to the role, having, over the course of his career, advanced more than ten radioligands through various stages of...
Evotec and Bayer announce new kidney disease study
Evotec and Bayer have announced the initiation of a phase 2 clinical study in kidney disease, stemming from their previous collaborative research in this area. The phase 2a ASSESS study will evaluate the efficacy and safety of BAY 3401016, a monoclonal antibody targeting the protein...
Grid-scale battery energy storage systems face heightened risk of cyberattack
Experts warn that state-linked threat groups are actively searching for ways to disrupt the industry amid growing power demand in the U.S. Continue reading →